comparemela.com

Latest Breaking News On - More such health news - Page 8 : comparemela.com

AstraZeneca: New Data Shows Tezspire s Role In Future COPD Treatment

THOUSAND OAKS (dpa-AFX) - The primary results from the Phase IIa COURSE trial showed that treatment with AstraZeneca and Amgen's Tezspire (tezepelumab) led to a 17% numerical reduction in the annual

Amgen tezspireMore such health newsRespiratory questionnaireIhr portfolio

Zai Lab, Innoviva: China Oks XACDURO For Hospital-Acquired, Ventilator-Associated Pneumonia In 18+

Zai Lab Ltd. (ZLAB) and Innoviva Specialty Therapeutics announced Monday that China's National Medical Products Administration or NMPA has approved Zai Lab's New Drug Application for XACDURO (sulbactam-durlobactam) to treat hospital-acquired and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus complex in China.

Harald reinhartEntasis therapeutics incChina national medical products administrationHead of global developmentZai labZai lab new drug applicationDrug administrationZai lab ltdMore such health newsWorld health organizationInnoviva specialty therapeuticsNational medical products administrationNew drug applicationGreater chinaGlobal developmentInfectious diseases

AstraZeneca To Build $1 5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates

(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Monday that it intends to build a $1.5 billion manufacturing facility in Si.

United kingdomPascal soriotSingapore economic development boardMore such health newsAstrazeneca plcChief executive officer

Mars Petcare Recalls Select PEDIGREE Dry Dog Food Sold By Walmart

(RTTNews) - Mars Petcare US Inc. is recalling 44 lb. Bag of Pedigree Adult Complete Nutrition Grilled Steak & Vegetable Flavor Dry dog food citing.

United statesMars petcare us incDrug administrationMore such health newsPedigree adult complete nutrition grilled steakVegetable flavor dryBest by dateLot codeMars petcareNutrena country feeds meat

Gilead s Seladelpar Shows Major Liver Disease Progression Improvement, Itch Reduction In PBC Study

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to

Gilead sciences incMore such health newsIhr portfolio

vimarsana © 2020. All Rights Reserved.